Evidence map›Paper›PMID 31842787›Full record

Observational studyBMC nephrology2019

Epidemiology of acute kidney injury in intensive care units in Beijing: the multi-center BAKIT study.

Li Jiang, Yibing Zhu, Xuying Luo, Ying Wen, Bin Du, Meiping Wang, Zhen Zhao, Yanyan Yin, Bo Zhu, Xiuming Xi and 1 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Li JiangDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Yibing ZhuDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China. yiyi_bingbing@163.com.
Xuying LuoDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Ying WenDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Bin DuMedical ICU, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, 1 Shuai Fu Yuan, Beijing, 100730, China.
Meiping WangDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Zhen ZhaoDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Yanyan YinDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Bo ZhuDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China.
Xiuming XiDepartment of Critical Care Medicine, Fuxing Hospital, Capital Medical University, 20A Fuxingmenwai Street, Xicheng District, Beijing, 100038, China. xxm2937@sina.com.
Beijing Acute Kidney Injury Trial (BAKIT) workgroup

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) commonly occurs in intensive care units (ICUs), leading to adverse clinical outcomes and increasing costs. However, there are limited epidemiological data of AKI in the critically ill in Beijing, China.

methodsIn this prospective cohort study in 30 ICUs, we screened the patients up to 10 days after ICU admission. Characteristics and outcomes were compared between AKI and non-AKI, renal replacement therapy (RRT) and non-RRT patients. Nomograms of logistic regression and Cox regression were performed to examine potential risk factors for AKI and mortality.

resultsA total of 3107 patients were included in the final analysis. The incidence of AKI was 51.0%; stages 1 to 3 accounted for 23.1, 11.8, and 15.7%, respectively. The majority (87.6%) of patients with AKI developed AKI on the first 4 days after admission to the ICU. A total of 281 patients were treated with RRT. Continuous RRT with predilution, citrate for anticoagulation and femoral vein for vascular access was the most common RRT pattern (29.9%, 84 of 281). Patients with AKI were associated with longer ICU-LOS and higher mortality and costs (P<0.001). In patients treated with RRT, 78.6 and 28.5% of RRTs were dependent on the 7th and 28th days, respectively. The 28 day mortalities of non-AKI, AKI stages 1-3, and septic shock patients were 6.83, 15.04, 27.99, 45.18 and 36.5%, respectively.

conclusionsApproximately half of our ICU patients experienced AKI. The majority of patients with AKI developed AKI during the first 4 days after admission to the ICU. Continuous RRT with predilution, citrate for anticoagulation and femoral vein for vascular access was the most common RRT pattern in our ICUs. AKI was associated with a higher mortality and costs, incomplete kidney recovery and s series of adverse outcomes.

Indexed as

Intensive Care UnitsAcute Kidney InjuryAgedBeijingCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesRenal Replacement TherapyAcute kidney injuryCritical care medicineEpidemiologyMortalityRenal replacement therapy

Identifiers

PMID31842787
PMCPMC6915890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.